Navellier & Associates’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $502K | Buy |
6,203
+148
| +2% | +$14.2K | 0.04% | 230 |
|
|
2026
Q2 | $578K | Buy |
6,055
+1,639
| +37% | +$157K | 0.05% | 233 |
|
|
2026
Q1 | $458K | Sell |
4,416
-8
| -0.2% | -$907 | 0.05% | 225 |
|
|
2025
Q4 | $446K | Sell |
4,424
-1,352
| -23% | -$147K | 0.05% | 230 |
|
|
2025
Q3 | $712K | Buy |
5,776
+1,161
| +25% | +$144K | 0.07% | 215 |
|
|
2025
Q2 | $554K | Buy |
4,615
+10
| +0.2% | +$1.33K | 0.07% | 202 |
|
|
2025
Q1 | $637K | Buy |
+4,605
| New | +$703K | 0.09% | 185 |
|
|
2021
Q4 | – | Sell |
-1,346
| Closed | -$223K | – | 320 |
|
|
2021
Q3 | $223K | Hold |
1,346
| – | – | 0.03% | 288 |
|
|
2021
Q2 | $242K | Sell |
1,346
-12,083
| -90% | -$2.21M | 0.04% | 269 |
|
|
2021
Q1 | $2.59M | Sell |
13,429
-25,611
| -66% | -$4.93M | 0.47% | 71 |
|
|
2020
Q4 | $7.88M | Buy |
39,040
+2,521
| +7% | +$522K | 1.43% | 13 |
|
|
2020
Q3 | $7.68M | Sell |
36,519
-27,359
| -43% | -$6.09M | 1.67% | 7 |
|
|
2020
Q2 | $14M | Buy |
63,878
+59,003
| +1,210% | +$11.8M | 3.33% | 2 |
|
|
2020
Q1 | $845K | Buy |
+4,875
| New | +$805K | 0.2% | 100 |
|
|
2016
Q4 | – | Sell |
-84,351
| Closed | -$10.6M | – | 280 |
|
|
2016
Q3 | $10.6M | Sell |
84,351
-8,584
| -9% | -$1.12M | 1.51% | 14 |
|
|
2016
Q2 | $12.9M | Sell |
92,935
-49,752
| -35% | -$6.45M | 1.92% | 12 |
|
|
2016
Q1 | $18M | Buy |
142,687
+26,073
| +22% | +$3.31M | 2.34% | 11 |
|
|
2015
Q4 | $14.8M | Buy |
116,614
+114,009
| +4,377% | +$14.2M | 1.63% | 27 |
|
|
2015
Q3 | $301K | Buy |
2,605
+156
| +6% | +$17.5K | 0.03% | 217 |
|
|
2015
Q2 | $255K | Buy |
2,449
+359
| +17% | +$38.7K | 0.02% | 303 |
|
|
2015
Q1 | $231K | Sell |
2,090
-389
| -16% | -$42.2K | 0.02% | 315 |
|
|
2014
Q4 | $258K | Sell |
2,479
-8
| -0.3% | -$800 | 0.01% | 278 |
|
|
2014
Q3 | $239K | Buy |
2,487
+52
| +2% | +$4.7K | 0.01% | 289 |
|
|
2014
Q2 | $223K | Sell |
2,435
-667
| -22% | -$59.7K | 0.01% | 294 |
|
|
2014
Q1 | $273K | Sell |
3,102
-386,829
| -99% | -$34M | 0.01% | 269 |
|
|
2013
Q4 | $36.2M | Sell |
389,931
-44,447
| -10% | -$4M | 1.63% | 35 |
|
|
2013
Q3 | $35.5M | Sell |
434,378
-8,020
| -2% | -$677K | 1.05% | 53 |
|
|
2013
Q2 | $36.8M | Buy |
+442,398
| New | +$38.1M | 1.75% | 29 |
|
Other funds holding CLX
Navellier & Associates's CLX Position: Q3 2026 in Review
Navellier & Associates increased its Clorox (CLX) stake by 2.4% in Q3 2026, buying an estimated $14.2K and bringing the position to 6,203 shares worth $502K. The position accounts for 0.04% of the portfolio, ranked #230.
Navellier & Associates first reported a position in CLX in Q2 2013 and has held it in 28 quarters since. The position peaked at $36.8M in Q2 2013. 982 funds tracked by Wall St. Rank hold CLX as of Q3 2026.
- Navellier & Associates held 6,203 shares of Clorox worth $502K as of Q3 2026.
- Navellier & Associates bought 148 Clorox shares in Q3 2026, an estimated $14.2K.
- Clorox made up 0.04% of Navellier & Associates's portfolio in Q3 2026, its #230 holding.
- Navellier & Associates first reported a position in Clorox in Q2 2013 and has held it in 28 quarters since.
- Navellier & Associates's Clorox position peaked at $36.8M in Q2 2013.
- 982 funds tracked by Wall St. Rank held Clorox as of Q3 2026.
Based on Navellier & Associates's 13F filing for Q3 2026, filed 12 Nov 2026.